应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
HSCT HOOPS SCOUTING USA
休市中 05-09 16:00:00 EDT 延时
资讯
新帖
简况
【汇宇制药:注射用塞替派获药品注册证书】汇宇制药公告,全资子公司四川汇宇海玥医药科技有限公司于近日收到国家药品监督管理局核准签发的注射用塞替派获得的《药品注册证书》。药品适用于重型β-地中海贫血儿童(<18周岁)异基因造血干细胞移植(allo-HSCT)前预处理。塞替派是一种多功能的细胞毒类药物,其化学结构和药理作用与氮芥相关。注射用塞替派目前国内仅有江苏恒瑞1家企业持有本品的批件,公司为第二家视同通过仿制药质量和疗效一致性评价的企业。
金融界 · 03-11
【汇宇制药:注射用塞替派获药品注册证书】汇宇制药公告,全资子公司四川汇宇海玥医药科技有限公司于近日收到国家药品监督管理局核准签发的注射用塞替派获得的《药品注册证书》。药品适用于重型β-地中海贫血儿童(<18周岁)异基因造血干细胞移植(allo-HSCT)前预处理。塞替派是一种多功能的细胞毒类药物,其化学结构和药理作用与氮芥相关。注射用塞替派目前国内仅有江苏恒瑞1家企业持有本品的批件,公司为第二家视同通过仿制药质量和疗效一致性评价的企业。
Diabetes Care:儿童和青年癌症治疗后的糖尿病风险
亿欧网 · 02-20
Diabetes Care:儿童和青年癌症治疗后的糖尿病风险
加载更多
公司概况
公司名称:
HOOPS SCOUTING USA
所属市场:
EXPERT
上市日期:
--
主营业务:
发行价格:
--
{"stockData":{"symbol":"HSCT","market":"US","secType":"STK","nameCN":"HOOPS SCOUTING USA","latestPrice":0.0901,"timestamp":1746820800000,"preClose":0.0901,"halted":0,"volume":0,"delay":15,"floatShares":26250000,"shares":101250000,"eps":-0.002199,"marketStatus":"休市中","change":0,"latestTime":"05-09 16:00:00 EDT 延时","open":0.0901,"high":0.0901,"low":0.0901,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"otc":true,"ttmEps":-0.002199,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1747036800000},"marketStatusCode":7,"adr":0,"exchange":"EXPERT","adjPreClose":0.0901,"volumeRatio":1.176401325877231},"requestUrl":"/m/hq/s/HSCT","defaultTab":"news","newsList":[{"id":"2518171390","title":"【汇宇制药:注射用塞替派获药品注册证书】汇宇制药公告,全资子公司四川汇宇海玥医药科技有限公司于近日收到国家药品监督管理局核准签发的注射用塞替派获得的《药品注册证书》。药品适用于重型β-地中海贫血儿童(<18周岁)异基因造血干细胞移植(allo-HSCT)前预处理。塞替派是一种多功能的细胞毒类药物,其化学结构和药理作用与氮芥相关。注射用塞替派目前国内仅有江苏恒瑞1家企业持有本品的批件,公司为第二家视同通过仿制药质量和疗效一致性评价的企业。","url":"https://stock-news.laohu8.com/highlight/detail?id=2518171390","media":"金融界","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518171390?lang=zh_cn&edition=full","pubTime":"2025-03-11 17:43","pubTimestamp":1741686222,"startTime":"0","endTime":"0","summary":"汇宇制药公告,全资子公司四川汇宇海玥医药科技有限公司于近日收到国家药品监督管理局核准签发的注射用塞替派获得的《药品注册证书》。药品适用于重型β-地中海贫血儿童(<18周岁)异基因造血干细胞移植(allo-HSCT)前预处理。塞替派是一种多功能的细胞毒类药物,其化学结构和药理作用与氮芥相关。注射用塞替派目前国内仅有江苏恒瑞1家企业持有本品的批件,公司为第二家视同通过仿制药质量和疗效一致性评价的企业。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/03/11174348660575.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["159938","BK0239","HSCT","BK1515","BK1161","09939","BK1574","688553"],"gpt_icon":0},{"id":"2512464684","title":"Diabetes Care:儿童和青年癌症治疗后的糖尿病风险","url":"https://stock-news.laohu8.com/highlight/detail?id=2512464684","media":"亿欧网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512464684?lang=zh_cn&edition=full","pubTime":"2025-02-20 11:54","pubTimestamp":1740023668,"startTime":"0","endTime":"0","summary":"研究共纳入4,238名患者,中位随访时间为14.4年,期间确诊163例糖尿病患者。这些发现强调了特定治疗方法与长期糖尿病风险之间的关联,有助于指导未来的临床决策和随访管理。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://ky.jrj.com.cn/2025/02/20115448274750.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK4130","HSCT","TBI"],"gpt_icon":0}],"profile":{"websiteUrl":"https://hoopsscoutingusa.com/","exchange":"EXPERT","name":"HOOPS SCOUTING USA","nameEN":"HOOPS SCOUTING USA"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.33.4","shortVersion":"4.33.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"HOOPS SCOUTING USA(HSCT)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供HOOPS SCOUTING USA(HSCT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"HOOPS SCOUTING USA,HSCT,HOOPS SCOUTING USA股票,HOOPS SCOUTING USA股票老虎,HOOPS SCOUTING USA股票老虎国际,HOOPS SCOUTING USA行情,HOOPS SCOUTING USA股票行情,HOOPS SCOUTING USA股价,HOOPS SCOUTING USA股市,HOOPS SCOUTING USA股票价格,HOOPS SCOUTING USA股票交易,HOOPS SCOUTING USA股票购买,HOOPS SCOUTING USA股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"HOOPS SCOUTING USA(HSCT)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供HOOPS SCOUTING USA(HSCT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}